Drug · DIN 02408473
TEVA-EXEMESTANE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 17, 2025; first marketed October 1, 2013.
- Drug Identification Number (DIN)
- 02408473
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Exemestane L02BG06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EXEMESTANE | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 26, 2015: NOC 14768Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies